Telerehabilitation in Hemodialysis Patients.
Launched by HARTCENTRUM HASSELT · Mar 20, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Chronic kidney disease (CKD) is the third most common cause of death, with a prevalence of 10-12% among men and women. Prior studies indicate that individuals receiving hemodialysis (HD) perform less physical activity (PA) than healthy individuals due to the frequency and duration of hemodialysis sessions, which typically occur two to three times per week and last between three and four hours per session. Despite recommendations from the World Health Organization (WHO) that individuals undergoing HD should exercise for at least 30 minutes per day, most do not achieve these recommended level...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants with end-stage renal disease receiving in-center hemodialysis at the frequency of two to three times a week, with each session lasting ≥ 3 h
- • Age ≥18 years
- • Having signed and dated an informed consent form, indicating that the subject (or a legally-recognized representative) has been informed of all pertinent aspects of the study
- • Possession of and/or able to use a smartphone
- • Possession of internet connectivity
- • Dutch speaking and understanding
- • Be clinically stable
- • Willing and physically able to follow a technology-supported physical activity intervention and other study procedures in a six months follow-up period
- Exclusion Criteria:
- • Orthopedic, neurologic or any other pathologic condition which makes the participant physically unable to technology-supported physical activity intervention and other study procedures in a six months follow-up period
- • Cognitive disabilities or mental illnesses
- • Any condition which in the opinion of the investigator would make it unsafe or unsuitable for the participant to participate in this study or a life expectancy of less than three months based on investigators judgement
- • Participants who were hospitalized at the time of recruitment
- • Current or recent participation in other technology-supported programs, even when not directly targeting exercise capacity
About Hartcentrum Hasselt
Hartcentrum Hasselt is a leading cardiovascular research institute dedicated to advancing the understanding and treatment of heart-related conditions. With a strong emphasis on clinical trials, the center collaborates with healthcare professionals, researchers, and academic institutions to explore innovative therapies and improve patient outcomes. Hartcentrum Hasselt is committed to ethical practices and rigorous scientific standards, ensuring the integrity of its research initiatives while prioritizing patient safety and well-being. Through its comprehensive approach, the center aims to contribute significantly to the field of cardiology and enhance the quality of care for patients with cardiovascular diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hasselt, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported